目次

Table of Contents

1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive landscape

2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Generics
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Generics in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators
7.1. Country data

8 Generics in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators
9.1. Country data

10 Generics in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators
11.1. Country data

12 Generics in Australia
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators
13.1. Country data

14 Generics in Brazil
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators
15.1. Country data

16 Generics in Canada
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators
17.1. Country data

18 Generics in China
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators
19.1. Country data

20 Generics in India
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators
21.1. Country data

22 Generics in Indonesia
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators
23.1. Country data

24 Generics in Italy
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators
25.1. Country data

26 Generics in Japan
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators
27.1. Country data

28 Generics in Mexico
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators
29.1. Country data

30 Generics in The Netherlands
30.1. Market Overview
30.2. Market Data
30.3. Market Segmentation
30.4. Market outlook
30.5. Five forces analysis

31 Macroeconomic Indicators
31.1. Country data

32 Generics in North America
32.1. Market Overview
32.2. Market Data
32.3. Market Segmentation
32.4. Market outlook
32.5. Five forces analysis

33 Generics in Russia
33.1. Market Overview
33.2. Market Data
33.3. Market Segmentation
33.4. Market outlook
33.5. Five forces analysis

34 Macroeconomic Indicators
34.1. Country data

35 Generics in Scandinavia
35.1. Market Overview
35.2. Market Data
35.3. Market Segmentation
35.4. Market outlook
35.5. Five forces analysis

36 Generics in Singapore
36.1. Market Overview
36.2. Market Data
36.3. Market Segmentation
36.4. Market outlook
36.5. Five forces analysis

37 Macroeconomic Indicators
37.1. Country data

38 Generics in South Africa
38.1. Market Overview
38.2. Market Data
38.3. Market Segmentation
38.4. Market outlook
38.5. Five forces analysis

39 Macroeconomic Indicators
39.1. Country data

40 Generics in South Korea
40.1. Market Overview
40.2. Market Data
40.3. Market Segmentation
40.4. Market outlook
40.5. Five forces analysis

41 Macroeconomic Indicators
41.1. Country data

42 Generics in Spain
42.1. Market Overview
42.2. Market Data
42.3. Market Segmentation
42.4. Market outlook
42.5. Five forces analysis

43 Macroeconomic Indicators
43.1. Country data

44 Generics in Turkey
44.1. Market Overview
44.2. Market Data
44.3. Market Segmentation
44.4. Market outlook
44.5. Five forces analysis

45 Macroeconomic Indicators
45.1. Country data

46 Generics in The United Kingdom
46.1. Market Overview
46.2. Market Data
46.3. Market Segmentation
46.4. Market outlook
46.5. Five forces analysis

47 Macroeconomic Indicators
47.1. Country data

48 Generics in The United States
48.1. Market Overview
48.2. Market Data
48.3. Market Segmentation
48.4. Market outlook
48.5. Five forces analysis

49 Macroeconomic Indicators
49.1. Country data

50 Company Profiles
50.1. Teva Pharmaceutical Industries Limited
50.2. Pfizer Inc.
50.3. Sun Pharmaceutical Industries Ltd
50.4. Viatris Inc.
50.5. Sanofi SA
50.6. Les Laboratoires Servier
50.7. STADA Arzneimittel AG
50.8. Novartis AG
50.9. Lupin Ltd
50.10. Aspen Pharmacare Holdings Ltd
50.11. EMS SA
50.12. Ache Laboratorios Farmaceuticos SA
50.13. Eurofarma Laboratorios SA
50.14. Apotex, Inc.
50.15. Grand Pharmaceutical Group Limited
50.16. Aurobindo Pharma Ltd
50.17. Cipla Limited
50.18. PT Kalbe Farma Tbk
50.19. PT Sanbe Farma
50.20. PT Soho Global Health Tbk
50.21. PT Indofarma (Persero), Tbk
50.22. Daiichi Sankyo Co Ltd
50.23. Sawai Pharmaceutical Co Ltd
50.24. Krka, d. d., Novo mesto
50.25. Abbott Laboratories
50.26. Adcock Ingram Holdings Ltd
50.27. Yuhan Corp
50.28. Esteve Group
50.29. Deva Holding AS
50.30. Nobelpharma Co Ltd
50.31. Abdi Ibrahim Ilac Sanayi ve Ticaret AS

51 Appendix
51.1. Methodology
51.2. About MarketLine

List of Tables
Table 1: Global generics market value: $ million, 2017-22
Table 2: Global generics market volume: %, 2017-22
Table 3: Global generics market geography segmentation: $ million, 2022
Table 4: Global generics market value forecast: $ million, 2022-27
Table 5: Global generics market volume forecast: %, 2022-27
Table 6: Global size of population (million), 2018-22
Table 7: Global gdp (constant 2005 prices, $ billion), 2018-22
Table 8: Global gdp (current prices, $ billion), 2018-22
Table 9: Global inflation, 2018-22
Table 10: Global consumer price index (absolute), 2018-22
Table 11: Global exchange rate, 2018-22
Table 12: Asia-Pacific generics market value: $ million, 2017-22
Table 13: Asia-Pacific generics market volume: %, 2017-22
Table 14: Asia-Pacific generics market geography segmentation: $ million, 2022
Table 15: Asia-Pacific generics market value forecast: $ million, 2022-27
Table 16: Asia-Pacific generics market volume forecast: %, 2022-27
Table 17: Europe generics market value: $ million, 2017-22
Table 18: Europe generics market volume: %, 2017-22
Table 19: Europe generics market geography segmentation: $ million, 2022
Table 20: Europe generics market value forecast: $ million, 2022-27
Table 21: Europe generics market volume forecast: %, 2022-27
Table 22: Europe size of population (million), 2018-22
Table 23: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 24: Europe gdp (current prices, $ billion), 2018-22
Table 25: Europe inflation, 2018-22
Table 26: Europe consumer price index (absolute), 2018-22
Table 27: Europe exchange rate, 2018-22
Table 28: France generics market value: $ million, 2017-22
Table 29: France generics market volume: %, 2017-22
Table 30: France generics market geography segmentation: $ million, 2022
Table 31: France generics market value forecast: $ million, 2022-27
Table 32: France generics market volume forecast: %, 2022-27
Table 33: France size of population (million), 2018-22
Table 34: France gdp (constant 2005 prices, $ billion), 2018-22
Table 35: France gdp (current prices, $ billion), 2018-22
Table 36: France inflation, 2018-22
Table 37: France consumer price index (absolute), 2018-22
Table 38: France exchange rate, 2018-22
Table 39: Germany generics market value: $ million, 2017-22
Table 40: Germany generics market volume: %, 2017-22
Table 41: Germany generics market geography segmentation: $ million, 2022
Table 42: Germany generics market value forecast: $ million, 2022-27
Table 43: Germany generics market volume forecast: %, 2022-27
Table 44: Germany size of population (million), 2018-22
Table 45: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 46: Germany gdp (current prices, $ billion), 2018-22
Table 47: Germany inflation, 2018-22
Table 48: Germany consumer price index (absolute), 2018-22
Table 49: Germany exchange rate, 2018-22
Table 50: Australia generics market value: $ million, 2017-22
Table 51: Australia generics market volume: %, 2017-22
Table 52: Australia generics market geography segmentation: $ million, 2022
Table 53: Australia generics market value forecast: $ million, 2022-27
Table 54: Australia generics market volume forecast: %, 2022-27
Table 55: Australia size of population (million), 2018-22
Table 56: Australia gdp (constant 2005 prices, $ billion), 2018-22
Table 57: Australia gdp (current prices, $ billion), 2018-22
Table 58: Australia inflation, 2018-22
Table 59: Australia consumer price index (absolute), 2018-22
Table 60: Australia exchange rate, 2018-22
Table 61: Brazil generics market value: $ million, 2017-22
Table 62: Brazil generics market volume: %, 2017-22
Table 63: Brazil generics market geography segmentation: $ million, 2022
Table 64: Brazil generics market value forecast: $ million, 2022-27
Table 65: Brazil generics market volume forecast: %, 2022-27
Table 66: Brazil size of population (million), 2018-22
Table 67: Brazil gdp (constant 2005 prices, $ billion), 2018-22
Table 68: Brazil gdp (current prices, $ billion), 2018-22
Table 69: Brazil inflation, 2018-22
Table 70: Brazil consumer price index (absolute), 2018-22
Table 71: Brazil exchange rate, 2018-22
Table 72: Canada generics market value: $ million, 2017-22
Table 73: Canada generics market volume: %, 2017-22
Table 74: Canada generics market geography segmentation: $ million, 2022
Table 75: Canada generics market value forecast: $ million, 2022-27
Table 76: Canada generics market volume forecast: %, 2022-27
Table 77: Canada size of population (million), 2018-22
Table 78: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 79: Canada gdp (current prices, $ billion), 2018-22
Table 80: Canada inflation, 2018-22
Table 81: Canada consumer price index (absolute), 2018-22
Table 82: Canada exchange rate, 2018-22
Table 83: China generics market value: $ million, 2017-22
Table 84: China generics market volume: %, 2017-22
Table 85: China generics market geography segmentation: $ million, 2022
Table 86: China generics market value forecast: $ million, 2022-27
Table 87: China generics market volume forecast: %, 2022-27
Table 88: China size of population (million), 2018-22
Table 89: China gdp (constant 2005 prices, $ billion), 2018-22
Table 90: China gdp (current prices, $ billion), 2018-22
Table 91: China inflation, 2018-22
Table 92: China consumer price index (absolute), 2018-22
Table 93: China exchange rate, 2018-22
Table 94: India generics market value: $ million, 2017-22
Table 95: India generics market volume: %, 2017-22
Table 96: India generics market geography segmentation: $ million, 2022
Table 97: India generics market value forecast: $ million, 2022-27
Table 98: India generics market volume forecast: %, 2022-27
Table 99: India size of population (million), 2018-22
Table 100: India gdp (constant 2005 prices, $ billion), 2018-22
Table 101: India gdp (current prices, $ billion), 2018-22
Table 102: India inflation, 2018-22
Table 103: India consumer price index (absolute), 2018-22
Table 104: India exchange rate, 2018-22
Table 105: Indonesia generics market value: $ million, 2017-22
Table 106: Indonesia generics market volume: %, 2017-22
Table 107: Indonesia generics market geography segmentation: $ million, 2022
Table 108: Indonesia generics market value forecast: $ million, 2022-27
Table 109: Indonesia generics market volume forecast: %, 2022-27
Table 110: Indonesia size of population (million), 2018-22
Table 111: Indonesia gdp (constant 2005 prices, $ billion), 2018-22
Table 112: Indonesia gdp (current prices, $ billion), 2018-22
Table 113: Indonesia inflation, 2018-22
Table 114: Indonesia consumer price index (absolute), 2018-22
Table 115: Indonesia exchange rate, 2018-22
Table 116: Italy generics market value: $ million, 2017-22
Table 117: Italy generics market volume: %, 2017-22
Table 118: Italy generics market geography segmentation: $ million, 2022
Table 119: Italy generics market value forecast: $ million, 2022-27
Table 120: Italy generics market volume forecast: %, 2022-27
Table 121: Italy size of population (million), 2018-22
Table 122: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 123: Italy gdp (current prices, $ billion), 2018-22
Table 124: Italy inflation, 2018-22
Table 125: Italy consumer price index (absolute), 2018-22
Table 126: Italy exchange rate, 2018-22
Table 127: Japan generics market value: $ million, 2017-22
Table 128: Japan generics market volume: %, 2017-22
Table 129: Japan generics market geography segmentation: $ million, 2022
Table 130: Japan generics market value forecast: $ million, 2022-27
Table 131: Japan generics market volume forecast: %, 2022-27
Table 132: Japan size of population (million), 2018-22
Table 133: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 134: Japan gdp (current prices, $ billion), 2018-22
Table 135: Japan inflation, 2018-22
Table 136: Japan consumer price index (absolute), 2018-22
Table 137: Japan exchange rate, 2018-22
Table 138: Mexico generics market value: $ million, 2017-22
Table 139: Mexico generics market volume: %, 2017-22
Table 140: Mexico generics market geography segmentation: $ million, 2022
Table 141: Mexico generics market value forecast: $ million, 2022-27
Table 142: Mexico generics market volume forecast: %, 2022-27
Table 143: Mexico size of population (million), 2018-22
Table 144: Mexico gdp (constant 2005 prices, $ billion), 2018-22
Table 145: Mexico gdp (current prices, $ billion), 2018-22
Table 146: Mexico inflation, 2018-22
Table 147: Mexico consumer price index (absolute), 2018-22
Table 148: Mexico exchange rate, 2018-22
Table 149: Netherlands generics market value: $ million, 2017-22
Table 150: Netherlands generics market volume: %, 2017-22
Table 151: Netherlands generics market geography segmentation: $ million, 2022
Table 152: Netherlands generics market value forecast: $ million, 2022-27
Table 153: Netherlands generics market volume forecast: %, 2022-27
Table 154: Netherlands size of population (million), 2018-22
Table 155: Netherlands gdp (constant 2005 prices, $ billion), 2018-22
Table 156: Netherlands gdp (current prices, $ billion), 2018-22
Table 157: Netherlands inflation, 2018-22
Table 158: Netherlands consumer price index (absolute), 2018-22
Table 159: Netherlands exchange rate, 2018-22
Table 160: North America generics market value: $ million, 2017-22
Table 161: North America generics market volume: %, 2017-22
Table 162: North America generics market geography segmentation: $ million, 2022
Table 163: North America generics market value forecast: $ million, 2022-27
Table 164: North America generics market volume forecast: %, 2022-27
Table 165: Russia generics market value: $ million, 2017-22
Table 166: Russia generics market volume: %, 2017-22
Table 167: Russia generics market geography segmentation: $ million, 2022
Table 168: Russia generics market value forecast: $ million, 2022-27
Table 169: Russia generics market volume forecast: %, 2022-27
Table 170: Russia size of population (million), 2018-22
Table 171: Russia gdp (constant 2005 prices, $ billion), 2018-22
Table 172: Russia gdp (current prices, $ billion), 2018-22
Table 173: Russia inflation, 2018-22
Table 174: Russia consumer price index (absolute), 2018-22
Table 175: Russia exchange rate, 2018-22
Table 176: Scandinavia generics market value: $ million, 2017-22
Table 177: Scandinavia generics market volume: %, 2017-22
Table 178: Scandinavia generics market geography segmentation: $ million, 2022
Table 179: Scandinavia generics market value forecast: $ million, 2022-27
Table 180: Scandinavia generics market volume forecast: %, 2022-27
Table 181: Singapore generics market value: $ million, 2017-22
Table 182: Singapore generics market volume: %, 2017-22
Table 183: Singapore generics market geography segmentation: $ million, 2022
Table 184: Singapore generics market value forecast: $ million, 2022-27
Table 185: Singapore generics market volume forecast: %, 2022-27
Table 186: Singapore size of population (million), 2018-22
Table 187: Singapore gdp (constant 2005 prices, $ billion), 2018-22
Table 188: Singapore gdp (current prices, $ billion), 2018-22
Table 189: Singapore inflation, 2018-22
Table 190: Singapore consumer price index (absolute), 2018-22
Table 191: Singapore exchange rate, 2018-22
Table 192: South Africa generics market value: $ million, 2017-22
Table 193: South Africa generics market volume: %, 2017-22
Table 194: South Africa generics market geography segmentation: $ million, 2022
Table 195: South Africa generics market value forecast: $ million, 2022-27
Table 196: South Africa generics market volume forecast: %, 2022-27
Table 197: South Africa size of population (million), 2018-22
Table 198: South Africa gdp (constant 2005 prices, $ billion), 2018-22
Table 199: South Africa gdp (current prices, $ billion), 2018-22
Table 200: South Africa inflation, 2018-22
Table 201: South Africa consumer price index (absolute), 2018-22
Table 202: South Africa exchange rate, 2018-22
Table 203: South Korea generics market value: $ million, 2017-22
Table 204: South Korea generics market volume: %, 2017-22
Table 205: South Korea generics market geography segmentation: $ million, 2022
Table 206: South Korea generics market value forecast: $ million, 2022-27
Table 207: South Korea generics market volume forecast: %, 2022-27
Table 208: South Korea size of population (million), 2018-22
Table 209: South Korea gdp (constant 2005 prices, $ billion), 2018-22
Table 210: South Korea gdp (current prices, $ billion), 2018-22
Table 211: South Korea inflation, 2018-22
Table 212: South Korea consumer price index (absolute), 2018-22
Table 213: South Korea exchange rate, 2018-22
Table 214: Spain generics market value: $ million, 2017-22
Table 215: Spain generics market volume: %, 2017-22
Table 216: Spain generics market geography segmentation: $ million, 2022
Table 217: Spain generics market value forecast: $ million, 2022-27
Table 218: Spain generics market volume forecast: %, 2022-27
Table 219: Spain size of population (million), 2018-22
Table 220: Spain gdp (constant 2005 prices, $ billion), 2018-22
Table 221: Spain gdp (current prices, $ billion), 2018-22
Table 222: Spain inflation, 2018-22
Table 223: Spain consumer price index (absolute), 2018-22
Table 224: Spain exchange rate, 2018-22
Table 225: Turkey generics market value: $ million, 2017-22
Table 226: Turkey generics market volume: %, 2017-22
Table 227: Turkey generics market geography segmentation: $ million, 2022
Table 228: Turkey generics market value forecast: $ million, 2022-27
Table 229: Turkey generics market volume forecast: %, 2022-27
Table 230: Turkey size of population (million), 2018-22
Table 231: Turkey gdp (constant 2005 prices, $ billion), 2018-22
Table 232: Turkey gdp (current prices, $ billion), 2018-22
Table 233: Turkey inflation, 2018-22
Table 234: Turkey consumer price index (absolute), 2018-22
Table 235: Turkey exchange rate, 2018-22
Table 236: United Kingdom generics market value: $ million, 2017-22
Table 237: United Kingdom generics market volume: %, 2017-22
Table 238: United Kingdom generics market geography segmentation: $ million, 2022
Table 239: United Kingdom generics market value forecast: $ million, 2022-27
Table 240: United Kingdom generics market volume forecast: %, 2022-27
Table 241: United Kingdom size of population (million), 2018-22
Table 242: United Kingdom gdp (constant 2005 prices, $ billion), 2018-22
Table 243: United Kingdom gdp (current prices, $ billion), 2018-22
Table 244: United Kingdom inflation, 2018-22
Table 245: United Kingdom consumer price index (absolute), 2018-22
Table 246: United Kingdom exchange rate, 2018-22
Table 247: United States generics market value: $ million, 2017-22
Table 248: United States generics market volume: %, 2017-22
Table 249: United States generics market geography segmentation: $ million, 2022
Table 250: United States generics market value forecast: $ million, 2022-27
Table 251: United States generics market volume forecast: %, 2022-27
Table 252: United States size of population (million), 2018-22
Table 253: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 254: United States gdp (current prices, $ billion), 2018-22
Table 255: United States inflation, 2018-22
Table 256: United States consumer price index (absolute), 2018-22
Table 257: United States exchange rate, 2018-22
Table 258: Teva Pharmaceutical Industries Limited: key facts
Table 259: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 260: Teva Pharmaceutical Industries Limited: Key Employees
Table 261: Pfizer Inc.: key facts
Table 262: Pfizer Inc.: Annual Financial Ratios
Table 263: Pfizer Inc.: Key Employees
Table 264: Pfizer Inc.: Key Employees Continued
Table 265: Sun Pharmaceutical Industries Ltd: key facts
Table 266: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 267: Sun Pharmaceutical Industries Ltd: Key Employees
Table 268: Viatris Inc.: key facts
Table 269: Viatris Inc.: Annual Financial Ratios
Table 270: Viatris Inc.: Key Employees
Table 271: Viatris Inc.: Key Employees Continued
Table 272: Sanofi SA: key facts
Table 273: Sanofi SA: Annual Financial Ratios
Table 274: Sanofi SA: Key Employees
Table 275: Sanofi SA: Key Employees Continued
Table 276: Les Laboratoires Servier: key facts
Table 277: Les Laboratoires Servier: Key Employees
Table 278: STADA Arzneimittel AG: key facts
Table 279: STADA Arzneimittel AG: Key Employees
Table 280: Novartis AG: key facts
Table 281: Novartis AG: Annual Financial Ratios
Table 282: Novartis AG: Key Employees
Table 283: Novartis AG: Key Employees Continued
Table 284: Lupin Ltd: key facts
Table 285: Lupin Ltd: Annual Financial Ratios
Table 286: Lupin Ltd: Key Employees
Table 287: Aspen Pharmacare Holdings Ltd: key facts
Table 288: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 289: Aspen Pharmacare Holdings Ltd: Key Employees
Table 290: EMS SA: key facts
Table 291: EMS SA: Key Employees
Table 292: Ache Laboratorios Farmaceuticos SA: key facts
Table 293: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 294: Eurofarma Laboratorios SA: key facts
Table 295: Eurofarma Laboratorios SA: Key Employees
Table 296: Apotex, Inc.: key facts
Table 297: Apotex, Inc.: Key Employees
Table 298: Grand Pharmaceutical Group Limited: key facts
Table 299: Grand Pharmaceutical Group Limited: Annual Financial Ratios
Table 300: Grand Pharmaceutical Group Limited: Key Employees
Table 301: Aurobindo Pharma Ltd: key facts
Table 302: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 303: Aurobindo Pharma Ltd: Key Employees
Table 304: Cipla Limited: key facts
Table 305: Cipla Limited: Annual Financial Ratios
Table 306: Cipla Limited: Key Employees
Table 307: PT Kalbe Farma Tbk: key facts
Table 308: PT Kalbe Farma Tbk: Annual Financial Ratios
Table 309: PT Kalbe Farma Tbk: Key Employees
Table 310: PT Sanbe Farma: key facts
Table 311: PT Sanbe Farma: Key Employees
Table 312: PT Soho Global Health Tbk: key facts
Table 313: PT Soho Global Health Tbk: Annual Financial Ratios
Table 314: PT Soho Global Health Tbk: Key Employees
Table 315: PT Indofarma (Persero), Tbk: key facts
Table 316: PT Indofarma (Persero), Tbk: Annual Financial Ratios
Table 317: PT Indofarma (Persero), Tbk: Key Employees
Table 318: Daiichi Sankyo Co Ltd: key facts
Table 319: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 320: Daiichi Sankyo Co Ltd: Key Employees
Table 321: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 322: Sawai Pharmaceutical Co Ltd: key facts
Table 323: Sawai Pharmaceutical Co Ltd: Key Employees
Table 324: Krka, d. d., Novo mesto: key facts
Table 325: Krka, d. d., Novo mesto: Annual Financial Ratios
Table 326: Krka, d. d., Novo mesto: Key Employees
Table 327: Krka, d. d., Novo mesto: Key Employees Continued
Table 328: Abbott Laboratories: key facts
Table 329: Abbott Laboratories: Annual Financial Ratios
Table 330: Abbott Laboratories: Key Employees
Table 331: Abbott Laboratories: Key Employees Continued
Table 332: Adcock Ingram Holdings Ltd: key facts
Table 333: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 334: Adcock Ingram Holdings Ltd: Key Employees
Table 335: Yuhan Corp: key facts
Table 336: Yuhan Corp: Annual Financial Ratios
Table 337: Yuhan Corp: Key Employees
Table 338: Yuhan Corp: Key Employees Continued
Table 339: Esteve Group: key facts
Table 340: Esteve Group: Key Employees
Table 341: Deva Holding AS: key facts
Table 342: Deva Holding AS: Annual Financial Ratios
Table 343: Deva Holding AS: Key Employees
Table 344: Nobelpharma Co Ltd: key facts
Table 345: Nobelpharma Co Ltd: Key Employees
Table 346: Nobelpharma Co Ltd: Key Employees Continued
Table 347: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: key facts
Table 348: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees

List of Figures
Figure 1: Global generics market value: $ million, 2017-22
Figure 2: Global generics market volume: %, 2017-22
Figure 3: Global generics market geography segmentation: % share, by value, 2022
Figure 4: Global generics market value forecast: $ million, 2022-27
Figure 5: Global generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the global generics market, 2022
Figure 7: Drivers of buyer power in the global generics market, 2022
Figure 8: Drivers of supplier power in the global generics market, 2022
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2022
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2022
Figure 11: Drivers of degree of rivalry in the global generics market, 2022
Figure 12: Asia-Pacific generics market value: $ million, 2017-22
Figure 13: Asia-Pacific generics market volume: %, 2017-22
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2022
Figure 15: Asia-Pacific generics market value forecast: $ million, 2022-27
Figure 16: Asia-Pacific generics market volume forecast: %, 2022-27
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2022
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2022
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2022
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2022
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2022
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2022
Figure 23: Europe generics market value: $ million, 2017-22
Figure 24: Europe generics market volume: %, 2017-22
Figure 25: Europe generics market geography segmentation: % share, by value, 2022
Figure 26: Europe generics market value forecast: $ million, 2022-27
Figure 27: Europe generics market volume forecast: %, 2022-27
Figure 28: Forces driving competition in the generics market in Europe, 2022
Figure 29: Drivers of buyer power in the generics market in Europe, 2022
Figure 30: Drivers of supplier power in the generics market in Europe, 2022
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2022
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2022
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2022
Figure 34: France generics market value: $ million, 2017-22
Figure 35: France generics market volume: %, 2017-22
Figure 36: France generics market geography segmentation: % share, by value, 2022
Figure 37: France generics market value forecast: $ million, 2022-27
Figure 38: France generics market volume forecast: %, 2022-27
Figure 39: Forces driving competition in the generics market in France, 2022
Figure 40: Drivers of buyer power in the generics market in France, 2022
Figure 41: Drivers of supplier power in the generics market in France, 2022
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2022
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2022
Figure 44: Drivers of degree of rivalry in the generics market in France, 2022
Figure 45: Germany generics market value: $ million, 2017-22
Figure 46: Germany generics market volume: %, 2017-22
Figure 47: Germany generics market geography segmentation: % share, by value, 2022
Figure 48: Germany generics market value forecast: $ million, 2022-27
Figure 49: Germany generics market volume forecast: %, 2022-27
Figure 50: Forces driving competition in the generics market in Germany, 2022
Figure 51: Drivers of buyer power in the generics market in Germany, 2022
Figure 52: Drivers of supplier power in the generics market in Germany, 2022
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2022
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2022
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2022
Figure 56: Australia generics market value: $ million, 2017-22
Figure 57: Australia generics market volume: %, 2017-22
Figure 58: Australia generics market geography segmentation: % share, by value, 2022
Figure 59: Australia generics market value forecast: $ million, 2022-27
Figure 60: Australia generics market volume forecast: %, 2022-27
Figure 61: Forces driving competition in the generics market in Australia, 2022
Figure 62: Drivers of buyer power in the generics market in Australia, 2022
Figure 63: Drivers of supplier power in the generics market in Australia, 2022
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Australia, 2022
Figure 65: Factors influencing the threat of substitutes in the generics market in Australia, 2022
Figure 66: Drivers of degree of rivalry in the generics market in Australia, 2022
Figure 67: Brazil generics market value: $ million, 2017-22
Figure 68: Brazil generics market volume: %, 2017-22
Figure 69: Brazil generics market geography segmentation: % share, by value, 2022
Figure 70: Brazil generics market value forecast: $ million, 2022-27
Figure 71: Brazil generics market volume forecast: %, 2022-27
Figure 72: Forces driving competition in the generics market in Brazil, 2022
Figure 73: Drivers of buyer power in the generics market in Brazil, 2022
Figure 74: Drivers of supplier power in the generics market in Brazil, 2022
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2022
Figure 76: Factors influencing the threat of substitutes in the generics market in Brazil, 2022
Figure 77: Drivers of degree of rivalry in the generics market in Brazil, 2022
Figure 78: Canada generics market value: $ million, 2017-22
Figure 79: Canada generics market volume: %, 2017-22
Figure 80: Canada generics market geography segmentation: % share, by value, 2022
Figure 81: Canada generics market value forecast: $ million, 2022-27
Figure 82: Canada generics market volume forecast: %, 2022-27
Figure 83: Forces driving competition in the generics market in Canada, 2022
Figure 84: Drivers of buyer power in the generics market in Canada, 2022
Figure 85: Drivers of supplier power in the generics market in Canada, 2022
Figure 86: Factors influencing the likelihood of new entrants in the generics market in Canada, 2022
Figure 87: Factors influencing the threat of substitutes in the generics market in Canada, 2022
Figure 88: Drivers of degree of rivalry in the generics market in Canada, 2022
Figure 89: China generics market value: $ million, 2017-22
Figure 90: China generics market volume: %, 2017-22
Figure 91: China generics market geography segmentation: % share, by value, 2022
Figure 92: China generics market value forecast: $ million, 2022-27
Figure 93: China generics market volume forecast: %, 2022-27
Figure 94: Forces driving competition in the generics market in China, 2022
Figure 95: Drivers of buyer power in the generics market in China, 2022
Figure 96: Drivers of supplier power in the generics market in China, 2022
Figure 97: Factors influencing the likelihood of new entrants in the generics market in China, 2022
Figure 98: Factors influencing the threat of substitutes in the generics market in China, 2022
Figure 99: Drivers of degree of rivalry in the generics market in China, 2022
Figure 100: India generics market value: $ million, 2017-22
Figure 101: India generics market volume: %, 2017-22
Figure 102: India generics market geography segmentation: % share, by value, 2022
Figure 103: India generics market value forecast: $ million, 2022-27
Figure 104: India generics market volume forecast: %, 2022-27
Figure 105: Forces driving competition in the generics market in India, 2022
Figure 106: Drivers of buyer power in the generics market in India, 2022
Figure 107: Drivers of supplier power in the generics market in India, 2022
Figure 108: Factors influencing the likelihood of new entrants in the generics market in India, 2022
Figure 109: Factors influencing the threat of substitutes in the generics market in India, 2022
Figure 110: Drivers of degree of rivalry in the generics market in India, 2022
Figure 111: Indonesia generics market value: $ million, 2017-22
Figure 112: Indonesia generics market volume: %, 2017-22
Figure 113: Indonesia generics market geography segmentation: % share, by value, 2022
Figure 114: Indonesia generics market value forecast: $ million, 2022-27
Figure 115: Indonesia generics market volume forecast: %, 2022-27
Figure 116: Forces driving competition in the generics market in Indonesia, 2022
Figure 117: Drivers of buyer power in the generics market in Indonesia, 2022
Figure 118: Drivers of supplier power in the generics market in Indonesia, 2022
Figure 119: Factors influencing the likelihood of new entrants in the generics market in Indonesia, 2022
Figure 120: Factors influencing the threat of substitutes in the generics market in Indonesia, 2022
Figure 121: Drivers of degree of rivalry in the generics market in Indonesia, 2022
Figure 122: Italy generics market value: $ million, 2017-22
Figure 123: Italy generics market volume: %, 2017-22
Figure 124: Italy generics market geography segmentation: % share, by value, 2022
Figure 125: Italy generics market value forecast: $ million, 2022-27
Figure 126: Italy generics market volume forecast: %, 2022-27
Figure 127: Forces driving competition in the generics market in Italy, 2022
Figure 128: Drivers of buyer power in the generics market in Italy, 2022
Figure 129: Drivers of supplier power in the generics market in Italy, 2022
Figure 130: Factors influencing the likelihood of new entrants in the generics market in Italy, 2022
Figure 131: Factors influencing the threat of substitutes in the generics market in Italy, 2022
Figure 132: Drivers of degree of rivalry in the generics market in Italy, 2022
Figure 133: Japan generics market value: $ million, 2017-22
Figure 134: Japan generics market volume: %, 2017-22
Figure 135: Japan generics market geography segmentation: % share, by value, 2022
Figure 136: Japan generics market value forecast: $ million, 2022-27
Figure 137: Japan generics market volume forecast: %, 2022-27
Figure 138: Forces driving competition in the generics market in Japan, 2022
Figure 139: Drivers of buyer power in the generics market in Japan, 2022
Figure 140: Drivers of supplier power in the generics market in Japan, 2022
Figure 141: Factors influencing the likelihood of new entrants in the generics market in Japan, 2022
Figure 142: Factors influencing the threat of substitutes in the generics market in Japan, 2022
Figure 143: Drivers of degree of rivalry in the generics market in Japan, 2022
Figure 144: Mexico generics market value: $ million, 2017-22
Figure 145: Mexico generics market volume: %, 2017-22
Figure 146: Mexico generics market geography segmentation: % share, by value, 2022
Figure 147: Mexico generics market value forecast: $ million, 2022-27
Figure 148: Mexico generics market volume forecast: %, 2022-27
Figure 149: Forces driving competition in the generics market in Mexico, 2022
Figure 150: Drivers of buyer power in the generics market in Mexico, 2022
Figure 151: Drivers of supplier power in the generics market in Mexico, 2022
Figure 152: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2022
Figure 153: Factors influencing the threat of substitutes in the generics market in Mexico, 2022
Figure 154: Drivers of degree of rivalry in the generics market in Mexico, 2022
Figure 155: Netherlands generics market value: $ million, 2017-22
Figure 156: Netherlands generics market volume: %, 2017-22
Figure 157: Netherlands generics market geography segmentation: % share, by value, 2022
Figure 158: Netherlands generics market value forecast: $ million, 2022-27
Figure 159: Netherlands generics market volume forecast: %, 2022-27
Figure 160: Forces driving competition in the generics market in the Netherlands, 2022
Figure 161: Drivers of buyer power in the generics market in the Netherlands, 2022
Figure 162: Drivers of supplier power in the generics market in the Netherlands, 2022
Figure 163: Factors influencing the likelihood of new entrants in the generics market in the Netherlands, 2022
Figure 164: Factors influencing the threat of substitutes in the generics market in the Netherlands, 2022
Figure 165: Drivers of degree of rivalry in the generics market in the Netherlands, 2022
Figure 166: North America generics market value: $ million, 2017-22
Figure 167: North America generics market volume: %, 2017-22
Figure 168: North America generics market geography segmentation: % share, by value, 2022
Figure 169: North America generics market value forecast: $ million, 2022-27
Figure 170: North America generics market volume forecast: %, 2022-27
Figure 171: Forces driving competition in the generics market in North America, 2022
Figure 172: Drivers of buyer power in the generics market in North America, 2022
Figure 173: Drivers of supplier power in the generics market in North America, 2022
Figure 174: Factors influencing the likelihood of new entrants in the generics market in North America, 2022
Figure 175: Factors influencing the threat of substitutes in the generics market in North America, 2022
Figure 176: Drivers of degree of rivalry in the generics market in North America, 2022
Figure 177: Russia generics market value: $ million, 2017-22
Figure 178: Russia generics market volume: %, 2017-22
Figure 179: Russia generics market geography segmentation: % share, by value, 2022
Figure 180: Russia generics market value forecast: $ million, 2022-27
Figure 181: Russia generics market volume forecast: %, 2022-27
Figure 182: Forces driving competition in the generics market in Russia, 2022
Figure 183: Drivers of buyer power in the generics market in Russia, 2022
Figure 184: Drivers of supplier power in the generics market in Russia, 2022
Figure 185: Factors influencing the likelihood of new entrants in the generics market in Russia, 2022
Figure 186: Factors influencing the threat of substitutes in the generics market in Russia, 2022
Figure 187: Drivers of degree of rivalry in the generics market in Russia, 2022
Figure 188: Scandinavia generics market value: $ million, 2017-22
Figure 189: Scandinavia generics market volume: %, 2017-22
Figure 190: Scandinavia generics market geography segmentation: % share, by value, 2022
Figure 191: Scandinavia generics market value forecast: $ million, 2022-27
Figure 192: Scandinavia generics market volume forecast: %, 2022-27
Figure 193: Forces driving competition in the generics market in Scandinavia, 2022
Figure 194: Drivers of buyer power in the generics market in Scandinavia, 2022
Figure 195: Drivers of supplier power in the generics market in Scandinavia, 2022
Figure 196: Factors influencing the likelihood of new entrants in the generics market in Scandinavia, 2022
Figure 197: Factors influencing the threat of substitutes in the generics market in Scandinavia, 2022
Figure 198: Drivers of degree of rivalry in the generics market in Scandinavia, 2022
Figure 199: Singapore generics market value: $ million, 2017-22
Figure 200: Singapore generics market volume: %, 2017-22
Figure 201: Singapore generics market geography segmentation: % share, by value, 2022
Figure 202: Singapore generics market value forecast: $ million, 2022-27
Figure 203: Singapore generics market volume forecast: %, 2022-27
Figure 204: Forces driving competition in the generics market in Singapore, 2022
Figure 205: Drivers of buyer power in the generics market in Singapore, 2022
Figure 206: Drivers of supplier power in the generics market in Singapore, 2022
Figure 207: Factors influencing the likelihood of new entrants in the generics market in Singapore, 2022
Figure 208: Factors influencing the threat of substitutes in the generics market in Singapore, 2022
Figure 209: Drivers of degree of rivalry in the generics market in Singapore, 2022
Figure 210: South Africa generics market value: $ million, 2017-22
Figure 211: South Africa generics market volume: %, 2017-22
Figure 212: South Africa generics market geography segmentation: % share, by value, 2022
Figure 213: South Africa generics market value forecast: $ million, 2022-27
Figure 214: South Africa generics market volume forecast: %, 2022-27
Figure 215: Forces driving competition in the generics market in South Africa, 2022
Figure 216: Drivers of buyer power in the generics market in South Africa, 2022
Figure 217: Drivers of supplier power in the generics market in South Africa, 2022
Figure 218: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2022
Figure 219: Factors influencing the threat of substitutes in the generics market in South Africa, 2022
Figure 220: Drivers of degree of rivalry in the generics market in South Africa, 2022
Figure 221: South Korea generics market value: $ million, 2017-22
Figure 222: South Korea generics market volume: %, 2017-22
Figure 223: South Korea generics market geography segmentation: % share, by value, 2022
Figure 224: South Korea generics market value forecast: $ million, 2022-27
Figure 225: South Korea generics market volume forecast: %, 2022-27
Figure 226: Forces driving competition in the generics market in South Korea, 2022
Figure 227: Drivers of buyer power in the generics market in South Korea, 2022
Figure 228: Drivers of supplier power in the generics market in South Korea, 2022
Figure 229: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2022
Figure 230: Factors influencing the threat of substitutes in the generics market in South Korea, 2022
Figure 231: Drivers of degree of rivalry in the generics market in South Korea, 2022
Figure 232: Spain generics market value: $ million, 2017-22
Figure 233: Spain generics market volume: %, 2017-22
Figure 234: Spain generics market geography segmentation: % share, by value, 2022
Figure 235: Spain generics market value forecast: $ million, 2022-27
Figure 236: Spain generics market volume forecast: %, 2022-27
Figure 237: Forces driving competition in the generics market in Spain, 2022
Figure 238: Drivers of buyer power in the generics market in Spain, 2022
Figure 239: Drivers of supplier power in the generics market in Spain, 2022
Figure 240: Factors influencing the likelihood of new entrants in the generics market in Spain, 2022
Figure 241: Factors influencing the threat of substitutes in the generics market in Spain, 2022
Figure 242: Drivers of degree of rivalry in the generics market in Spain, 2022
Figure 243: Turkey generics market value: $ million, 2017-22
Figure 244: Turkey generics market volume: %, 2017-22
Figure 245: Turkey generics market geography segmentation: % share, by value, 2022
Figure 246: Turkey generics market value forecast: $ million, 2022-27
Figure 247: Turkey generics market volume forecast: %, 2022-27
Figure 248: Forces driving competition in the generics market in Turkey, 2022
Figure 249: Drivers of buyer power in the generics market in Turkey, 2022
Figure 250: Drivers of supplier power in the generics market in Turkey, 2022
Figure 251: Factors influencing the likelihood of new entrants in the generics market in Turkey, 2022
Figure 252: Factors influencing the threat of substitutes in the generics market in Turkey, 2022
Figure 253: Drivers of degree of rivalry in the generics market in Turkey, 2022
Figure 254: United Kingdom generics market value: $ million, 2017-22
Figure 255: United Kingdom generics market volume: %, 2017-22
Figure 256: United Kingdom generics market geography segmentation: % share, by value, 2022
Figure 257: United Kingdom generics market value forecast: $ million, 2022-27
Figure 258: United Kingdom generics market volume forecast: %, 2022-27
Figure 259: Forces driving competition in the generics market in the United Kingdom, 2022
Figure 260: Drivers of buyer power in the generics market in the United Kingdom, 2022
Figure 261: Drivers of supplier power in the generics market in the United Kingdom, 2022
Figure 262: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2022
Figure 263: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2022
Figure 264: Drivers of degree of rivalry in the generics market in the United Kingdom, 2022
Figure 265: United States generics market value: $ million, 2017-22
Figure 266: United States generics market volume: %, 2017-22
Figure 267: United States generics market geography segmentation: % share, by value, 2022
Figure 268: United States generics market value forecast: $ million, 2022-27
Figure 269: United States generics market volume forecast: %, 2022-27
Figure 270: Forces driving competition in the generics market in the United States, 2022
Figure 271: Drivers of buyer power in the generics market in the United States, 2022
Figure 272: Drivers of supplier power in the generics market in the United States, 2022
Figure 273: Factors influencing the likelihood of new entrants in the generics market in the United States, 2022
Figure 274: Factors influencing the threat of substitutes in the generics market in the United States, 2022
Figure 275: Drivers of degree of rivalry in the generics market in the United States, 2022